Sarasota, FL, United States of America

Rapid Pathogen Screening, Inc.


USPTO Granted Patents = 29

% Expired Patents = 13.8



Trademarks = 6

Forward Citations = 147

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Robert P Sambursky (26 out of 27 patents)

silverMedal Uma Mahesh Babu (23 out of 24 patents)

bronzeMedal Robert W VanDine (22 out of 24 patents)

4.  Peter Condon (5 out of 5 patents)

5.  Franz Aberl (4 out of 5 patents)

6.  Marcus Scheibenzuber (4 out of 5 patents)

7.  Jose S Sambursky (4 out of 5 patents)

8.  Ganga V Kanaujia (3 out of 3 patents)

9.  Engelmundus Cornelis Ignatius Veerman (2 out of 5 patents)

10.  Thomas Orsini (2 out of 2 patents)

11.  Johannes Gerhardus Maria Bolscher (2 out of 3 patents)

12.  Arie Van Nieuw Amerongen (2 out of 3 patents)

13.  Menno Johannes Oudhoff (2 out of 3 patents)

14.  Willem Van't Hof (2 out of 3 patents)

15.  Kamran Nazmi (2 out of 3 patents)


Core Competencies:
Lateral Flow Assays
Immunoassay Systems
Viral Detection
Bacterial Detection
Mucolytic Agents
Sample Analysis
Infection Diagnosis
Specificity Enhancement
Peptide Applications
Fluorescence Detection
Histatin Use
Cell Lysis

29 patents:

Rapid Pathogen Screening, Inc. is a biotechnology company based in Sarasota, Florida, specializing in the development of innovative diagnostic solutions for infectious diseases. The organization focuses on creating rapid testing technologies that enhance the detection and identification of pathogens, thereby improving patient outcomes and streamlining healthcare processes. With a commitment to advancing medical diagnostics, the company aims to address critical needs in both clinical and public health settings.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

29 Patents

#10 in Sarasota, FL

#283 in Florida

#11,606 in US

#22,510 in the World

Sarasota, FL (US)
Sarasota, FL, United States of America
Forward Citations = 147

18 inventors:

Please report any incorrect information to [email protected]
Loading…